LT3063B - Injectable veterinary composition free from side toxic effects and process for the preparation thereof - Google Patents
Injectable veterinary composition free from side toxic effects and process for the preparation thereof Download PDFInfo
- Publication number
- LT3063B LT3063B LTIP165A LTIP165A LT3063B LT 3063 B LT3063 B LT 3063B LT IP165 A LTIP165 A LT IP165A LT IP165 A LTIP165 A LT IP165A LT 3063 B LT3063 B LT 3063B
- Authority
- LT
- Lithuania
- Prior art keywords
- weight
- parts
- water
- urea
- pyrimidine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title claims 4
- 231100000331 toxic Toxicity 0.000 title abstract description 6
- 230000002588 toxic effect Effects 0.000 title abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000004202 carbamide Substances 0.000 claims abstract description 14
- 239000003960 organic solvent Substances 0.000 claims abstract description 11
- 239000000654 additive Substances 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 5
- 230000000996 additive effect Effects 0.000 claims abstract description 4
- 230000000694 effects Effects 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 14
- 235000019441 ethanol Nutrition 0.000 claims description 13
- 239000002202 Polyethylene glycol Substances 0.000 claims description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 11
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 11
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 11
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 8
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 7
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 7
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 7
- 229960004011 methenamine Drugs 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 3
- 230000002411 adverse Effects 0.000 claims description 3
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 claims description 2
- 150000003627 tricarboxylic acid derivatives Chemical class 0.000 claims 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- -1 4-Aminophenylsulfonamide-5-methylisoxazole Chemical compound 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000005909 ethyl alcohol group Chemical group 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 239000010695 polyglycol Substances 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 abstract description 13
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 abstract description 12
- 239000000243 solution Substances 0.000 description 25
- 229960001082 trimethoprim Drugs 0.000 description 12
- 229960005404 sulfamethoxazole Drugs 0.000 description 10
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 108010024636 Glutathione Proteins 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- 230000003902 lesion Effects 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 3
- 235000010263 potassium metabisulphite Nutrition 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 150000003628 tricarboxylic acids Chemical class 0.000 description 3
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical class CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 2
- 229940093471 ethyl oleate Drugs 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000003801 Castanea crenata Nutrition 0.000 description 1
- 244000209117 Castanea crenata Species 0.000 description 1
- 208000025814 Inflammatory myopathy with abundant macrophages Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 101100118976 Mus musculus Clint1 gene Proteins 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000282330 Procyon lotor Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 206010028320 muscle necrosis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000010494 opalescence Effects 0.000 description 1
- 239000008203 oral pharmaceutical composition Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940006995 sulfamethoxazole and trimethoprim Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU322291A HU210693B (en) | 1991-10-11 | 1991-10-11 | Process for producing pharmaceutical compositions for injections without tissue damages, containing sulfamethoxazol and trimetoprime |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LTIP165A LTIP165A (lt) | 1994-03-25 |
| LT3063B true LT3063B (en) | 1994-10-25 |
Family
ID=10963176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTIP165A LT3063B (en) | 1991-10-11 | 1992-10-12 | Injectable veterinary composition free from side toxic effects and process for the preparation thereof |
Country Status (11)
| Country | Link |
|---|---|
| CN (1) | CN1035468C (ro) |
| BR (1) | BR9203951A (ro) |
| CZ (1) | CZ309392A3 (ro) |
| GB (1) | GB2260268B (ro) |
| HU (1) | HU210693B (ro) |
| LT (1) | LT3063B (ro) |
| MX (1) | MX9205808A (ro) |
| RO (1) | RO112241B1 (ro) |
| RU (1) | RU2059408C1 (ro) |
| SK (1) | SK309392A3 (ro) |
| YU (1) | YU91492A (ro) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7201928B1 (en) | 1999-09-21 | 2007-04-10 | Rutgers, The State University Of New Jersey | Extracts of orange peel for prevention and treatment of cancer |
| RU2603623C2 (ru) | 2014-06-06 | 2016-11-27 | Олег Ильич Эпштейн | Ветеринарная композиция и способ улучшения жизнеспособности животных, стимуляции прироста живой массы млекопитающих и птиц, повышения эффективности иммунизации, профилактики и/или лечения инфекционных заболеваний (варианты) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2538678A1 (de) | 1975-08-30 | 1977-03-03 | Boehringer Mannheim Gmbh | Injizierbare loesungen |
| GB2066068B (en) | 1979-11-27 | 1983-08-24 | Egyt Gyogyszervegyeszeti Gyar | Injectabel composition containing sulphamethoxazole |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4303643A (en) * | 1979-07-05 | 1981-12-01 | Pfizer Inc. | Sulfonamide compositions |
| IE49933B1 (en) * | 1979-07-05 | 1986-01-08 | Pfizer | Sulfonamide solutions |
| JPS57109713A (en) * | 1980-12-26 | 1982-07-08 | Shionogi & Co Ltd | Pharmaceutical preparation of combined agent of sulfamethoxazole and trimethoprim for medication through celom |
-
1991
- 1991-10-11 HU HU322291A patent/HU210693B/hu not_active IP Right Cessation
-
1992
- 1992-10-07 GB GB9221114A patent/GB2260268B/en not_active Expired - Fee Related
- 1992-10-09 MX MX9205808A patent/MX9205808A/es unknown
- 1992-10-09 SK SK309392A patent/SK309392A3/sk unknown
- 1992-10-09 BR BR929203951A patent/BR9203951A/pt not_active Application Discontinuation
- 1992-10-09 RU SU5052925 patent/RU2059408C1/ru active
- 1992-10-09 YU YU91492A patent/YU91492A/sh unknown
- 1992-10-09 CZ CS923093A patent/CZ309392A3/cs unknown
- 1992-10-09 RO RO9201296A patent/RO112241B1/ro unknown
- 1992-10-12 LT LTIP165A patent/LT3063B/lt not_active IP Right Cessation
- 1992-10-12 CN CN92111683A patent/CN1035468C/zh not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2538678A1 (de) | 1975-08-30 | 1977-03-03 | Boehringer Mannheim Gmbh | Injizierbare loesungen |
| GB2066068B (en) | 1979-11-27 | 1983-08-24 | Egyt Gyogyszervegyeszeti Gyar | Injectabel composition containing sulphamethoxazole |
Also Published As
| Publication number | Publication date |
|---|---|
| MX9205808A (es) | 1993-07-01 |
| LTIP165A (lt) | 1994-03-25 |
| YU91492A (sh) | 1995-12-04 |
| GB2260268A (en) | 1993-04-14 |
| HUT64839A (en) | 1994-03-28 |
| RO112241B1 (ro) | 1997-07-30 |
| CN1035468C (zh) | 1997-07-23 |
| SK309392A3 (en) | 1995-03-08 |
| GB9221114D0 (en) | 1992-11-18 |
| GB2260268B (en) | 1995-06-07 |
| HU210693B (en) | 1995-06-28 |
| HU913222D0 (en) | 1992-01-28 |
| CN1071576A (zh) | 1993-05-05 |
| BR9203951A (pt) | 1993-04-27 |
| RU2059408C1 (ru) | 1996-05-10 |
| CZ309392A3 (en) | 1994-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5082863A (en) | Pharmaceutical composition of florfenicol | |
| JP2002536315A (ja) | 安定な非水性単相粘性ビヒクルおよびそのようなビヒクルを使用する配合物 | |
| WO2001034114A1 (en) | Liquid heparin formulation | |
| CA2176223C (en) | Fenbendazole formulations | |
| EP0769951B1 (en) | Long-acting oxytetracycline composition | |
| US6310053B1 (en) | Long-acting oxytetracycline composition | |
| US6777448B2 (en) | Veterinary compositions for the treatment of parasitic diseases | |
| BRPI0619620A2 (pt) | composição, uso da mesma para o tratamento e controle de infecção ou infestação endo-e ectoparasìtica em um animal homeotérmico e processo para a preparação da composição | |
| US6110905A (en) | Long-acting oxytetracycline composition | |
| IE781425L (en) | Injectable chloroamphenicol solution | |
| JP2000247801A (ja) | 豚精液保存液及びその使用方法 | |
| CN1035468C (zh) | 一种无毒副作用的可注射的兽医组合物的制备方法 | |
| CA2194576C (en) | Long-acting oxytetracycline composition | |
| MXPA01005123A (es) | Formulacion antihelmintica inyectable. | |
| KR20020067781A (ko) | 구충용 이버멕틴 주사제 조성물 및 그 제조방법 | |
| HU208252B (en) | Process for producing solution against parasites and comprising avermectin derivative | |
| CN106806889A (zh) | 一种修复会阴侧切切口的组合物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TK9A | Rectifications: patents |
Free format text: 1. INJEKUOJAMA VETERINARINE KOMPOZICIJA, NETURINTI PASALINIO TOKSINIO POVEIKIO, KURIOS SUDETYJE AKTYVIOS MEDZIAGOS YRA 2,4-DIAMIN-5-/3 ,4 ,5 -TRIMETOKSIBENZIL/-PIRIMIDINAS IR 3-/4-AMINOFENILSULFONAMID/-5-METIL-IZOKSAZOLAS, B E S I S K I R I A N T I TUO, KAD PAPILDOMAI SAVO SUDETYJE TURI VIENA AR DAUGIAU ORGANINIU TIRPIKLIU, BESIMAISANCIU SU VANDENIU, VANDENI, VIENA AR DAUGIAU TIRPINIMO AGENTU, KARBAMIDA IR VIENA AR DAUGIAU PRIEDU, TOKIU KOMPONENTU SANTYKIU, SVORIO DALIMIS:2,4-DIAMIN-5-/3 ,4 ,5 -TRIMETOKSIBENZIL/-PIRIMIDINAS 0,8-63-/4 |
|
| MM9A | Lapsed patents |
Effective date: 19981012 |